EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Sundry Debtors History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹88 Cr | ₹100 Cr | ₹76 Cr | ₹69 Cr | ₹51 Cr |
What is the latest Sundry Debtors ratio of EVEREST ORGANICS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹88 Cr |
| Mar2024 | ₹100 Cr |
| Mar2023 | ₹76 Cr |
| Mar2022 | ₹69 Cr |
| Mar2021 | ₹51 Cr |
How is Sundry Debtors of EVEREST ORGANICS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹88 Cr | -11.64 | |
| Mar2024 | ₹100 Cr | 31.11 | |
| Mar2023 | ₹76 Cr | 11.33 | |
| Mar2022 | ₹69 Cr | 35.46 | |
| Mar2021 | ₹51 Cr | - | |
Compare Sundry Debtors of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹244.8 Cr | -5.7% | 5.3% | -42.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,893.0 Cr | -0.2% | 7.5% | 5.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,367.0 Cr | -0.9% | 11.5% | 9.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,241.0 Cr | 0.5% | 7% | 37.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,010.0 Cr | -3.1% | 4.8% | 10.3% | Stock Analytics | |
| CIPLA | ₹104,366.0 Cr | -5.4% | 5.5% | -13.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -5.7% |
5.3% |
-42.1% |
| SENSEX | -3.2% |
-3.9% |
-7.5% |
You may also like the below Video Courses